Press Release July 13, 2023 Acute Myeloid Leukemia Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 260+ Companies are working to improve the Treatment of Space | Takeda Oncology, Orca Bio, Gilead Sciences
Press Release July 13, 2023 Sanfilippo Syndrome Market Report 2032: Epidemiology, Market Size, Share, Therapies, Clinical Trials, Companies & Growth Analysis Report – Segmented By Therapies, Countries, by DelveInsight
Press Release July 13, 2023 Usher syndrome Market Report 2032: Epidemiology, Market Size, Share, Therapies, Clinical Trials, Companies & Growth Analysis Report – Segmented By Therapies, Countries, by DelveInsight
Press Release July 13, 2023 Spasticity Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019 -2032)|Key Companies |Companies – Ipsen Biopharmaceuticals, Inc, RVL Pharmaceuticals Merz Pharmaceuticals
Press Release July 13, 2023 Substance Use Disorder Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies|Companies-MediciNova,Omeros Corp, KemPharm, InterveXion Therapeutics
Press Release July 13, 2023 Rhino Conjunctivitis Market expected to rise | Companies – Lofarma S.p.A, Stallergenes Greer, HAL Allergy B.V., Mitacsm, Johnson & Johnson, Merck, Sanofi, GlaxoSmithKline, expected to drive market
Press Release July 13, 2023 Ovarian Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies|Companies-AbbVie, Green 3 Bio Inc, Sanofi, AstraZeneca
Press Release July 13, 2023 Nevoid Basal Cell Carcinoma Syndrome Market expected to rise | Companies – Novartis Pharmaceuticals, DUSA Pharmaceuticals, PellePharm, Palvella Therapeutics, expected to drive market
Press Release July 13, 2023 Inflammatory Myositis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019 -2032)|Key Companies – CSL Behring, Immunoforge Co. Ltd., Argenx Janssen
Press Release July 13, 2023 Liver Cirrhosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Madrigal Pharmaceuticals, Inc., Galectin Therapeutics Grifols Therapeutics,